Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Instrument Lambda is a Cambridge-based life sciences technology company specializing in ultra-sensitive protein analysis and single-molecule imaging. Spun out from the University of Cambridge, the company develops benchtop instrumentation designed to characterize protein-protein interactions and protein aggregation with unprecedented precision. Their platform aims to accelerate drug discovery for neurodegenerative diseases and other protein-misfolding disorders by providing detailed molecular insights that traditional bulk assays cannot capture. The company's technology leverages advanced optical physics to enable high-throughput, single-molecule detection in complex biological samples. By democratizing access to sophisticated biophysical tools, Instrument Lambda supports the development of novel therapeutics targeting complex proteomic pathways.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Instrument Lambda.